Last updated: 11/07/2018 14:55:49
A 16 week randomized, double-blind, parallel group, placebo-controlled study to evaluate the effect of rosiglitazone on myocardial glucose uptake in patients with type 2 diabetes and stable coronary heart disease.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A 16 week randomized, double-blind, parallel group, placebo-controlled study to evaluate the effect of rosiglitazone on myocardial glucose uptake in patients with type 2 diabetes and stable coronary heart disease.
Trial description: A 16 week randomized, double-blind, parallel group, placebo-controlled study to evaluate the effect of rosiglitazone on myocardial glucose uptake in patients with type 2 diabetes and stable coronary heart disease.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Lautamäki R, Airaksinen KEJ, Seppänen M et al. Rosiglitazone Improves Myocardial Glucose Uptake in Patients with Type 2 Diabetes and Coronary Artery Disease: A 16-Week Randomized, Double-Blind, Placebo-Controlled Study. Diabetes 2005; (54): 2787-2794.
Lautamäki R. Rosiglitazone Improves Myocardial Glucose Uptake in Ischemic Regions in Patients With Type 2 Diabetes: A 16-Week Randomized, Double-Blind, Placebo-Controlled Study. JACC 2005; Vol 45 (3), Suppl 1: 197 A, abstract 1006-222
Medical condition
Diabetes Mellitus, Type 2
Product
rosiglitazone
Collaborators
Not applicable
Study date(s)
August 2002 to February 2004
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2004-20-02
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website